Tag: Marksans
Browse our exclusive articles!
Marksans Pharma’s UK arm gets MHRA nod for pain-relief tablets
Marksans Pharma’s fully owned UK subsidiary, Relonchem Limited, has received authorisation from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) to market Mefenamic...
Marksans Pharma Q2 Results | Profit inches up as 12% revenue growth offset by margin pressure
Drug firm Marksans Pharma Ltd on Thursday (November 13) reported a net profit of ₹98.2 crore for the quarter ended September 2025, up 1.5%...
Marksans Pharma arm wins UK nod for high blood pressure drug Moxonidine
Marksans Pharma Ltd on Tuesday announced that its wholly owned UK subsidiary, Relonchem Limited, has received marketing authorisation from the UK Medicines and...
Marksans Pharma arm receives USFDA nod for acid reflux treatment drug
Marksans Pharma Ltd on Friday, August 8, said it has secured the final approval from the United States Food and Drug Administration (USFDA) for...
Marksans Pharma gains 3% as UK arm secures approval for muscle relaxant tablets
Marksans Pharma Ltd shares gained on Tuesday after its wholly owned UK subsidiary, Relonchem Ltd, secured Marketing Authorisation from the Medicines and Healthcare Products...
